International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome-Reference-Cited by-同舟云学术

International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome

Published:2022-01 Issue:1 Volume:149 Page:410-421.e7
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Dimitrova Dimana^ORCID,Nademi Zohreh,Maccari Maria Elena,Ehl Stephan,Uzel Gulbu,Tomoda Takahiro,Okano Tsubasa,Imai Kohsuke,Carpenter Benjamin,Ip Winnie,Rao Kanchan,Worth Austen J.J.,Laberko Alexandra,Mukhina Anna,Néven Bénédicte,Moshous Despina,Speckmann Carsten,Warnatz Klaus,Wehr Claudia,Abolhassani Hassan,Aghamohammadi Asghar,Bleesing Jacob J.,Dara Jasmeen,Dvorak Christopher C.,Ghosh Sujal,Kang Hyoung Jin,Markelj Gašper,Modi Arunkumar,Bayer Diana K.,Notarangelo Luigi D.,Schulz Ansgar,Garcia-Prat Marina,Soler-Palacín Pere,Karakükcü Musa,Yilmaz Ebru,Gambineri Eleonora,Menconi Mariacristina,Masmas Tania N.,Holm Mette,Bonfim Carmem,Prando Carolina,Hughes Stephen,Jolles Stephen,Morris Emma C.,Kapoor Neena,Koltan Sylwia,Paneesha Shankara,Steward Colin,Wynn Robert,Duffner Ulrich,Gennery Andrew R.,Lankester Arjan C.,Slatter Mary,Kanakry Jennifer A.

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference47 articles.

1. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage;Angulo;Science,2013

2. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency;Lucas;Nat Immunol,2014

3. Clinical spectrum and features of activated phosphoinositide 3-kinase delta syndrome: a large patient cohort study;Coulter;J Allergy Clin Immunol,2017

4. Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase delta syndrome 2: a cohort study;Elkaim;J Allergy Clin Immunol,2016

5. PI3Kdelta and primary immunodeficiencies;Lucas;Nat Rev Immunol,2016

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activated phosphoinositide 3‐kinase delta syndrome: Pathogenesis, clinical manifestations, and treatment;Pediatric Discovery;2024-08-23

2. Epstein–Barr virus-driven lymphoproliferation in inborn errors of immunity: a diagnostic and therapeutic challenge;Expert Review of Clinical Immunology;2024-07-30

3. Long-term treatment with selective PI3Kδ inhibitor leniolisib in adults with activated PI3Kδ syndrome;Blood Advances;2024-06-13

4. Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders;Global and Regional Health Technology Assessment;2024-05-22

5. Activated phosphoinositde 3-kinase (PI3Kδ) syndrome: an Italian point of view on diagnosis and new advances in treatment;Italian Journal of Pediatrics;2024-05-20